Page last updated: 2024-08-21

2-nitrobenzaldehyde and Ovarian Neoplasms

2-nitrobenzaldehyde has been researched along with Ovarian Neoplasms in 1 studies

*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Achar, RR; Alfaifi, MY; Barache, UB; Deodware, SA; Dhale, PC; Elbehairi, SEI; Flores-HolguĂ­n, N; Frau, J; Gaikwad, KD; Gaikwad, SH; Glossman-Mitnik, D; Kollur, SP; Shati, AA; Shivamallu, C; Silina, E; Stupin, V; Ubale, PA1

Other Studies

1 other study(ies) available for 2-nitrobenzaldehyde and Ovarian Neoplasms

ArticleYear
In Vitro Anticancer Screening, Molecular Docking and Antimicrobial Studies of Triazole-Based Nickel(II) Metal Complexes.
    Molecules (Basel, Switzerland), 2022, Oct-03, Volume: 27, Issue:19

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Apoptosis; Benzaldehydes; Cell Line, Tumor; Coordination Complexes; Female; Humans; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Nickel; Ovarian Neoplasms; Schiff Bases; Spectroscopy, Fourier Transform Infrared; Triazoles

2022